Follow Us:

Interleukin-1 Antagonists

IL-1 antagonists are a group of biological medicines that inhibit the activity of interleukin-1 (IL-1), an inflammatory cytokine involved in immune responses, inflammation and tissue damage. These medicines work by blocking IL-1 receptors or neutralising IL-1 activity, thereby reducing excessive inflammatory responses. Interleukin-1 inhibitors include anakinra, canakinumab and rilonacept, which act through different mechanisms. They are primarily used to treat selected autoimmune and autoinflammatory conditions, including rheumatoid arthritis, cryopyrin-associated periodic syndromes (CAPS), systemic juvenile idiopathic arthritis and recurrent pericarditis.